We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $17.2M
1-Year Est. Return 22.94%
This Fund
S&P 500
This Quarter Est. Return
+29.78%
1 Year Est. Return
-22.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.2M
AUM Growth
+$3.33M
Cap. Flow
-$483K
Cap. Flow %
-2.81%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$483K

Sector Composition

Rank Sector Weight
1 Healthcare 84.3%
2 Technology 15.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.94B
$14.5M 84.3%
3,951,141
IONQ icon
2
IonQ
IONQ
$15.9B
$2.7M 15.7%
50,705
-9,521
-16% -$483K

Similar funds

DCVC Opportunity Fund II's Q2 2026 Portfolio in Review

As of Q2 2026, DCVC Opportunity Fund II held 2 positions worth $17.2M, up 24% from $13.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. DCVC Opportunity Fund II opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 87% a quarter earlier, followed by Technology.

  • DCVC Opportunity Fund II's biggest Q2 2026 reduction was IonQ, cutting an estimated $483K.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $17.2M portfolio in Q2 2026.
  • DCVC Opportunity Fund II opened 0 new positions and closed 0 in Q2 2026.
  • DCVC Opportunity Fund II's portfolio value rose 24% quarter-over-quarter to $17.2M.

Based on DCVC Opportunity Fund II's 13F filing for Q2 2026, filed 14 Aug 2026.